Overview

Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer

Status:
Active, not recruiting

Trial end date:
2021-12-01

Target enrollment:

Participant gender:

Summary

This phase I trial is studying the side effects and best dose of docetaxel when given with radiation therapy and hormone therapy in patients with locally advanced prostate cancer.

Phase:

Phase 1

Details

Lead Sponsor:

David T. Marshall
Medical University of South Carolina

Treatments:

Bicalutamide
Docetaxel
Goserelin
Leuprolide